Results 271 to 280 of about 339,726 (399)

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

open access: yesBritish Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander   +5 more
wiley   +1 more source

Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl. [PDF]

open access: yesNPJ Vaccines
Romano IG   +11 more
europepmc   +1 more source

Morphine in Uræmic Convulsions [PDF]

open access: green, 1903
HOBART AMORY HARE   +5 more
openalex   +1 more source

Sex differences in the effects of maternal voluntary oral Cannabis consumption on the metabolic outcomes of high‐fat diet in adult offspring

open access: yesBritish Journal of Pharmacology, EarlyView.
Sex differences in the effects of maternal voluntary editable Cannabis consumption on the metabolic phenotype of adult offspring on a high‐fat diet. Abstract Background and Purpose Given the recent rise in Cannabis legalisation, accessibility to Cannabis and consumption have increased during pregnancy. Therefore, there could be unintended developmental
Nada A. Sallam   +5 more
wiley   +1 more source

(2R,6R)‐hydroxynorketamine prevents opioid abstinence‐related negative affect and stress‐induced reinstatement in mice

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Opioid use disorder (OUD) is a pressing public health concern marked by frequent relapse during periods of abstinence, perpetuated by negative affective states. Classical antidepressants or the currently prescribed opioid pharmacotherapies have limited efficacy to reverse the negative affect or prevent relapse ...
Andria Michael   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy